These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31416549)

  • 61. Glioblastoma multiforme fades on CT imaging after dexamethasone therapy.
    Hasegawa H; Pal D; Ramirez R; Ismail A; Marks P
    J Clin Neurosci; 2009 Dec; 16(12):1707-8. PubMed ID: 19766006
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
    Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
    Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
    Gutkin A; Cohen ZR; Peer D
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
    Khalifa J; Tensaouti F; Lotterie JA; Catalaa I; Chaltiel L; Benouaich-Amiel A; Gomez-Roca C; Noël G; Truc G; Péran P; Berry I; Sunyach MP; Charissoux M; Johnson C; Cohen-Jonathan Moyal E; Laprie A
    J Neurooncol; 2016 Oct; 130(1):181-192. PubMed ID: 27502603
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Elastic Statistical Shape Analysis of Biological Structures with Case Studies: A Tutorial.
    Cho MH; Asiaee A; Kurtek S
    Bull Math Biol; 2019 Jul; 81(7):2052-2073. PubMed ID: 31069599
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Brain tumor acidification using drugs simultaneously targeting multiple pH regulatory mechanisms.
    Albatany M; Ostapchenko VG; Meakin S; Bartha R
    J Neurooncol; 2019 Sep; 144(3):453-462. PubMed ID: 31392597
    [TBL] [Abstract][Full Text] [Related]  

  • 67. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
    Hsu YH; Ferl GZ; Ng CM
    Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series.
    Shin BJ; Burkhardt JK; Riina HA; Boockvar JA
    Neurosurg Clin N Am; 2012 Apr; 23(2):323-9, ix-x. PubMed ID: 22440875
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cerebral gumma mimicking glioblastoma multiforme.
    Ances BM; Danish SF; Kolson DL; Judy KD; Liebeskind DS
    Neurocrit Care; 2005; 2(3):300-2. PubMed ID: 16159080
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
    Lee EJ; terBrugge K; Mikulis D; Choi DS; Bae JM; Lee SK; Moon SY
    AJR Am J Roentgenol; 2011 Jan; 196(1):71-6. PubMed ID: 21178049
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [How useful are microsurgical operations in the treatment concept for glioblastoma multiforme].
    Stummer W; Tonn JC
    MMW Fortschr Med; 2004 Apr; 146(14):28-30. PubMed ID: 15344748
    [No Abstract]   [Full Text] [Related]  

  • 72. Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme.
    Lin YL; Chang KF; Huang XF; Hung CL; Chen SC; Chao WR; Liao KW; Tsai NM
    Int J Nanomedicine; 2015; 10():6009-20. PubMed ID: 26451107
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: A review.
    Mujokoro B; Adabi M; Sadroddiny E; Adabi M; Khosravani M
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1092-102. PubMed ID: 27612807
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Application of fuzzy c-means segmentation technique for tissue differentiation in MR images of a hemorrhagic glioblastoma multiforme.
    Phillips WE; Velthuizen RP; Phuphanich S; Hall LO; Clarke LP; Silbiger ML
    Magn Reson Imaging; 1995; 13(2):277-90. PubMed ID: 7739370
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion.
    Helson L; Majeed M
    Anticancer Res; 2019 Jul; 39(7):3423-3427. PubMed ID: 31262865
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drug cocktails for effective treatment of glioblastoma multiforme.
    Debinski W
    Expert Rev Neurother; 2008 Apr; 8(4):515-7. PubMed ID: 18416653
    [No Abstract]   [Full Text] [Related]  

  • 77. The Direction of Tumour Growth in Glioblastoma Patients.
    Esmaeili M; Stensjøen AL; Berntsen EM; Solheim O; Reinertsen I
    Sci Rep; 2018 Jan; 8(1):1199. PubMed ID: 29352231
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Simulating the behaviour of glioblastoma multiforme based on patient MRI during treatments.
    Alonzo F; Serandour AA; Saad M
    J Math Biol; 2022 Apr; 84(6):44. PubMed ID: 35482133
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Eddy-current-induced distortion correction using maximum reconciled mutual information in diffusion MR imaging.
    Liang J; Zhao S; Di L; Wang J; Sun P; Chai X; Li H
    Int J Comput Assist Radiol Surg; 2019 Mar; 14(3):463-472. PubMed ID: 30684107
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme.
    Elson A; Paulson E; Bovi J; Siker M; Schultz C; Laviolette PS
    J Neurooncol; 2015 May; 123(1):179-88. PubMed ID: 25894597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.